Decision aid tool for women with small uterine fibroids without symptoms
Builds and tests a decision aid for women with symptom-free small uterine leiomyoma.
Key facts
- Who runs it
- Shenzhen Maternity & Child Healthcare Hospital
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Establishment of a Decision Aid Tool for Asymptomatic Small Leiomyoma and Analysis of Influencing Factors for Clinical Decision-making Using HIFU
- Status
- Recruiting
- People taking part
- 120 people, planned
- Started
- 31 Aug 2022
- Expected to end
- 31 Aug 2027
- Type of study
- Observational, 2 groups
- Treatments tested
- Patients Decision Aids
- Record updated
- 12 August 2022
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women with small uterine fibroids (leiomyoma) that cause no symptoms. It tests a tool that helps patients decide about treatment, including HIFU (focused ultrasound).
- Age
- 18 to 55 years
- Sex
- Women only
- Disease stage
- Fibroids found on ultrasound and MRI, with no symptoms. On MRI, no more than 10 fibroids. The largest fibroid must be smaller than 5 cm (2 in) across.
- Earlier treatment
- You cannot join if you have had surgery to remove fibroids (myomectomy) by any method, or radiotherapy.
Main reasons for not taking part
- Pregnancy
- A fibroid 5cm (2 in) or larger, or a suspected cancer such as sarcoma
- Connective tissue disease, acute inflammation of the reproductive tract, or other gynecological disease such as endometriosis or ovarian tumors
- Unable to have sedation and pain relief, or language barriers
- Belly scars that block the ultrasound signal (more than 10mm range)
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Diagnosis of leiomyoma: patients with leiomyoma diagnosed by imaging examinations (ultrasound and MRI) have no clinical symptoms
- Female with age in 18-55 years old
- The maximum diameter of a single leiomyoma is less than 5m, and the number does not exceed 10 by MRI
- No contraindications for sedation and analgesia
- Patients and their families agree to join this study, and can follow up on time
Who cannot take part
- History of myomectomy, including transabdominal, laparoscopic, hysteroscopy, etc
- History of connective tissue diseases or radiotherapy, especially abdominal radiotherapy
- With pregnancy, acute inflammation of the reproductive tract, or other gynecological benign and malignant diseases such as endometriosis and ovarian tumors
- Suspected malignant tumor, such as sarcoma
- The maximum diameter of leiomyoma is greater than or equal to 5cm
- Those with language communication barriers and unable to cooperate with sedative and analgesic programs
- Abdominal scarring, when diagnosed by ultrasound transabdominal scan, has obvious sound attenuation (more than 10mm range)
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 55 years old?
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
With the younger patients diagnosed with asymptomatic leiomyoma, delay in the reproductive age of women, the advancement of medical technology, and the rapid development of treatment methods, there are many choices between gynecologists, gynecologists and patients because of experience and knowledge. It is not easy to make the most favorable choice for patients. This study is mainly led by a committee composed of designers, doctors, nurses and patients, and based on clinical guidelines and evidence-based medicine. Co-operating with patients with asymptomatic small leiomyoma, we want to find the influencing factors of clinical decision-making, and to establish a patient decision aid tool. We use prospective trial to verify that the use of this tool can improve patients' decision-making efficacy and further improve patient-reported outcomes.
The 2 groups in the trial
- communication without PADs
We use traditional communication ways to discuss the conditions with patients.
- communication with PADs
The committee, composed of designers, doctors, nurses and patients, bases on guidelines and evidence-based medicine to make a tool. And we use this tool to discuss the conditions with patients.
Treatment: Patients Decision Aids
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Establishment of a Decision Aid Tool for Asymptomatic Small Leiomyoma and Analysis of Influencing Factors for Clinical Decision-making Using HIFU
- Plain-language title
- Decision aid tool for women with small uterine fibroids without symptomsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT05500118, who can take part
- Record updated
- 12 August 2022